Haimerl M, Reich C
BMC Med Inform Decis Mak. 2025; 25(1):126.
PMID: 40069689
PMC: 11895222.
DOI: 10.1186/s12911-025-02909-9.
van den Broek-Altenburg E, Atherly A
J Med Internet Res. 2025; 27:e60443.
PMID: 39793021
PMC: 11759916.
DOI: 10.2196/60443.
Kook H, Kang D, Park Y, Kim N, Kang H, Jung I
Healthcare (Basel). 2024; 12(23).
PMID: 39685029
PMC: 11641232.
DOI: 10.3390/healthcare12232407.
Ameri H, Poder T
Int J Health Policy Manag. 2024; 13:8404.
PMID: 39620535
PMC: 11496749.
DOI: 10.34172/ijhpm.8404.
Zhu R, Ni J, Ren J, Li D, Xu J, Yu X
Front Oncol. 2024; 14:1464125.
PMID: 39605897
PMC: 11598703.
DOI: 10.3389/fonc.2024.1464125.
Developing a utility value set for the Gambling Quality of Life Scale-Brief (GQoLS-Brief) using a discrete choice experiment.
Luquiens A, Panjo H, Bonnaire C, Pelletier-Fleury N
Qual Life Res. 2024; 34(2):457-469.
PMID: 39592497
DOI: 10.1007/s11136-024-03835-5.
A transparent and standardized performance measurement platform is needed for on-prescription digital health apps to enable ongoing performance monitoring.
Welzel C, Bruckner S, Brightwell C, Fenech M, Gilbert S
PLOS Digit Health. 2024; 3(11):e0000656.
PMID: 39546536
PMC: 11567564.
DOI: 10.1371/journal.pdig.0000656.
The Short Form 6 Dimensions (SF-6D): Development and Evolution.
Mukuria C, Rowen D, Mulhern B, McDool E, Kharroubi S, Bjorner J
Appl Health Econ Health Policy. 2024; 23(1):19-33.
PMID: 39460886
PMC: 11729076.
DOI: 10.1007/s40258-024-00919-8.
Clinically meaningful outcomes in refractory metastatic colorectal cancer: a decade of defining and raising the bar.
Fakih M, Prager G, Tabernero J, Amellal N, Calleja E, Taieb J
ESMO Open. 2024; 9(11):103931.
PMID: 39395264
PMC: 11693422.
DOI: 10.1016/j.esmoop.2024.103931.
Deriving the PedsUtil health state classification system to measure health utilities for pediatric populations based on the PedsQL: a confirmatory factor analysis.
Kim DeLuca E, Dalziel K, Wittenberg E, Rose A, Prosser L
Health Qual Life Outcomes. 2024; 22(1):85.
PMID: 39380049
PMC: 11463099.
DOI: 10.1186/s12955-024-02300-8.
The Utility of [18]F-Fluorocholine Positron Emission Computed Tomography and [18]F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Evaluating Breast Cancer Phenotypes: A Pilot Study.
Zakaria M, Shaharudin S, Ahmad Saad F
Eurasian J Med. 2024; 56(2):78-85.
PMID: 39145500
PMC: 11332258.
DOI: 10.5152/eurasianjmed.2024.23047.
Magnitude and Temporal Variations of Socioeconomic Inequalities in the Quality of Life After Early Breast Cancer: Results From the Multicentric French CANTO Cohort.
Sandoval J, Franzoi M, Di Meglio A, Ferreira A, Viansone A, Andre F
J Clin Oncol. 2024; 42(24):2908-2917.
PMID: 38889372
PMC: 11328924.
DOI: 10.1200/JCO.23.02099.
Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.
James L, Klaassen F, Sweeney S, Furin J, Franke M, Yaesoubi R
PLoS Med. 2024; 21(5):e1004401.
PMID: 38701084
PMC: 11101189.
DOI: 10.1371/journal.pmed.1004401.
Is the QCI framework suited for monitoring outcomes and costs in a teaching hospital using value-based healthcare principles? A retrospective cohort study.
van Veghel W, van Dijk S, Klem T, Weel A, Bugel J, Birnie E
BMJ Open. 2024; 14(5):e080257.
PMID: 38692726
PMC: 11086573.
DOI: 10.1136/bmjopen-2023-080257.
Photocoagulation or sham laser in addition to conventional anti-VEGF therapy in macular edema associated with TelCaps due to diabetic macular edema or retinal vein occlusion (TalaDME): a study protocol for a multicentric, French, two-group,....
Dupas B, Castro-Farias D, Girmens J, Eginay A, Couturier A, Villeroy F
Trials. 2024; 25(1):273.
PMID: 38649937
PMC: 11034085.
DOI: 10.1186/s13063-024-07994-1.
Cancer population norms using a new value set for the SF-6Dv2 based on the preferences of patients with breast or colorectal cancer in Quebec.
Toure M, Sfairy S, Bedard S, McFadden N, Hanel R, Lemay F
Qual Life Res. 2024; 33(6):1605-1619.
PMID: 38642218
DOI: 10.1007/s11136-024-03653-9.
"It's hard to say anything definitive about what severity really is": lay conceptualisations of severity in a healthcare context.
Stenmarck M, Whitehurst D, Luras H, Rugkasa J
BMC Health Serv Res. 2024; 24(1):490.
PMID: 38641590
PMC: 11031975.
DOI: 10.1186/s12913-024-10892-6.
Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration.
Daroudi R, Zeraati H, Poder T, Norman R, Olyaeemanesh A, Akbari Sari A
Qual Life Res. 2024; 33(7):1853-1863.
PMID: 38630166
DOI: 10.1007/s11136-024-03649-5.
Optimal environmental testing frequency for outbreak surveillance.
Olejarz J, Oliveira Roster K, Kissler S, Lipsitch M, Grad Y
Epidemics. 2024; 46:100750.
PMID: 38394927
PMC: 10979539.
DOI: 10.1016/j.epidem.2024.100750.
Cost-effectiveness of the ONCORAL multidisciplinary programme for the management of outpatients taking oral anticancer agents at risk of drug-related event: protocol for a pragmatic randomised controlled study.
Huot L, Guerre P, Descotes G, Caffin A, Herledan C, Ranchon F
BMJ Open. 2024; 14(2):e074956.
PMID: 38367968
PMC: 10875583.
DOI: 10.1136/bmjopen-2023-074956.
